Increased DNA methylation variability in type 1 diabetes across three immune effector cell types

Paul, DS; Teschendorff, AE; Dang, MA; Lowe, R; Hawa, MI; Ecker, S; Beyan, H; Paul, DS; Teschendorff, AE; Dang, MA; Lowe, R; Hawa, MI; Ecker, S; Beyan, H; Cunningham, S; Fouts, AR; Ramelius, A; Burden, F; Farrow, S; Rowlston, S; Rehnstrom, K; Frontini, M; Downes, K; Busche, S; Cheung, WA; Ge, B; Simon, MM; Bujold, D; Kwan, T; Bourque, G; Datta, A; Lowy, E; Clarke, L; Flicek, P; Libertini, E; Heath, S; Gut, M; Gut, IG; Ouwehand, WH; Pastinen, T; Soranzo, N; Hofer, SE; Karges, B; Meissner, T; Boehm, BO; Cilio, C; Elding Larsson, H; Lernmark, Å; Steck, AK; Rakyan, VK; Beck, S; Leslie, RD; - view fewer (2016) Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nature Communications , 7 , Article 13555. 10.1038/ncomms13555 . Green open access

http://ift.tt/2gGLVr7